Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Hunter Syndrome Treatment Market: By Treatment Type: Enzyme Replacement Therapy (ERT), Others; By Complications; By Route of Administration; By End Use; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Hunter Syndrome Treatment Market Outlook

The global hunter syndrome treatment market attained a value of nearly USD 925 million in 2021. The market is estimated to grow in the forecast period of 2022-2027 at a CAGR of 6.30% to reach about USD 1334.6 million by 2027.

 

North America Holds a Considerable Share of the Market for Hunter Syndrome Treatment

The increasing awareness about rare diseases, surging healthcare expenditure, and strict regulations for orphan drug development are driving the growth of the hunter syndrome treatment market in North America. The United States holds a significant share in the market for hunter syndrome treatment in North America owing to recent advancements in medical sciences and the increasing coverings of government-sponsored health insurance. Meanwhile, the market for hunter syndrome treatment in the Asia Pacific region is likely to grow due to the robust growth of the healthcare industry in emerging economies like China and India. Moreover, the surging investments in advanced research and development (R&D) activities for novel treatment products of hunter syndrome in countries like India is expected to propel the market growth of hunter syndrome treatment during the forecast period.

 

Market Segmentation

Hunter syndrome is a unique, inherited disorder in which the body does not appropriately digest (break down) sugar molecules in the body. Treatment for hunter syndrome aids in the management of potential problems associated with the condition. The objective of treatment is to slow the progression of the disease and improve the quality of life. Enzyme replacement therapy is considered as one of the most effective treatments of hunter syndrome.

The market for hunter syndrome treatment, by treatment type, is divided into:

  • Enzyme Replacement Therapy (ERT)
    • Elaprase + Tak-609
    • Hunterase 
    • Izcargo 
  • Haematopoietic Stem Cell Transplant (HSCT)
    • Umbilical Cord Transplant
    • Bone Marrow Transplant
  • Others

The market can be broadly categorised on the basis of complications into:

  • Respiratory Disorders
  • Neurological Disorders
  • Cardiovascular
  • Musculoskeletal
  • Gastrointestinal Disorders
  • Ophthalmic
  • Audiologic
  • Dental
  • Others

Based on route of administration, the market is bifurcated into:

  • Intravenous
  • Intracerebroventricular (ICV)/ Intrathecal

By end use, the market is segmented into:

  • Hospitals
  • Speciality Clinics
  • Others

Based on the distribution channel, the market is classified into:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

The EMR report looks into the regional markets of hunter syndrome treatment like Latin America, North America, Europe, the Asia Pacific, and the Middle East and Africa.

 

Emergence of Novel Therapies Likely to Bolster the Market Growth of Hunter Syndrome Treatment

The increasing awareness regarding hunter syndrome and its treatment options, along with the growing healthcare infrastructure and the emergence of novel hunter syndrome therapies, is expected to drive the growth of the market during the forecast period. The increasing accessibility of therapeutic options and surging investments by various governments in the healthcare industry like sponsored health insurance are likely to propel the hunter syndrome treatment market growth. Technological advancements and innovations are also likely to provide lucrative opportunities to the market growth of hunter syndrome treatment.
 
Moreover, based on treatment type, enzyme replacement therapy (ERT) segment is projected to gain momentum over the forecast period in the market for hunter syndrome treatment across the globe as ERT has fewer side effects than other treatments and consists of longer drug history as well as wider availability.

 

Key Players in the Global Market for Hunter Syndrome Treatment

The report presents a detailed analysis of the following key players in the global hunter syndrome treatment market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Denali Therapeutics Inc.
  • ArmaGen, Inc.
  • Sangamo Therapeutics Inc.
  • CANbridge Life Sciences Ltd.
  • REGENXBIO Inc.
  • Others

The comprehensive report looks into the macro and micro aspects of the market. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Treatment Type
  • Complications
  • Route of Administration
  • End Use
  • Distribution Channel
  • Region
Breakup by Treatment Type
  • Enzyme Replacement Therapy (ERT)
    • Elaprase + Tak-609
    • Hunterase 
    • Izcargo 
  • Haematopoietic Stem Cell Transplant (HSCT)
    • Umbilical Cord Transplant
    • Bone Marrow Transplant
  • Others
Breakup by Complications
  • Respiratory Disorders
  • Neurological Disorders
  • Cardiovascular
  • Musculoskeletal
  • Gastrointestinal Disorders
  • Ophthalmic
  • Audiologic
  • Dental
  • Others
Breakup by Route of Administration
  • Intravenous
  • Intracerebroventricular (ICV)/ Intrathecal
Breakup by End Use
  • Hospitals
  • Speciality Clinics
  • Others
Breakup by Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Denali Therapeutics Inc.
  • ArmaGen, Inc.
  • Sangamo Therapeutics Inc.
  • CANbridge Life Sciences Ltd.
  • REGENXBIO Inc.
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Application
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Hunter Syndrome Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Hunter Syndrome Treatment Historical Market (2017-2021) 
    8.3    Global Hunter Syndrome Treatment Market Forecast (2022-2027)
    8.4    Global Hunter Syndrome Treatment Market by Treatment Type
        8.4.1    Enzyme Replacement Therapy (ERT)
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
            8.4.1.4    Breakup by Type
                8.4.1.4.1    Elaprase + Tak-609 
                8.4.1.4.2    Hunterase 
                8.4.1.4.3    Izcargo 
        8.4.2    Haematopoietic Stem Cell Transplant (HSCT)
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
            8.4.2.4    Breakup by Type
                8.4.2.4.1    Umbilical Cord Transplant    
                8.4.2.4.2    Bone Marrow Transplant
        8.4.3    Others
    8.5    Global Hunter Syndrome Treatment Market by Complications    
        8.5.1    Respiratory Disorders
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Neurological Disorders  
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Cardiovascular
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
        8.5.4    Musculoskeletal
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2017-2021)
            8.5.4.3    Forecast Trend (2022-2027)
        8.5.5    Gastrointestinal Disorders
            8.5.5.1    Market Share
            8.5.5.2    Historical Trend (2017-2021)
            8.5.5.3    Forecast Trend (2022-2027)
        8.5.6    Ophthalmic 
            8.5.6.1    Market Share
            8.5.6.2    Historical Trend (2017-2021)
            8.5.6.3    Forecast Trend (2022-2027)
        8.5.7    Audiologic
            8.5.7.1    Market Share
            8.5.7.2    Historical Trend (2017-2021)
            8.5.7.3    Forecast Trend (2022-2027)
        8.5.8    Dental
            8.5.8.1    Market Share
            8.5.8.2    Historical Trend (2017-2021)
            8.5.8.3    Forecast Trend (2022-2027)
        8.5.9    Others
    8.6    Global Hunter Syndrome Treatment Market by Route of Administration
        8.6.1    Intravenous
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Intracerebroventricular (ICV)/ Intrathecal
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
    8.7    Global Hunter Syndrome Treatment Market by End Use 
        8.7.1    Hospitals
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2017-2021)
            8.7.1.3    Forecast Trend (2022-2027)
        8.7.2    Speciality Clinics
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2017-2021)
            8.7.2.3    Forecast Trend (2022-2027)
        8.7.3    Others
    8.8    Global Hunter Syndrome Treatment Market by Distribution Channel 
        8.8.1    Hospital Pharmacy
            8.8.1.1    Market Share
            8.8.1.2    Historical Trend (2017-2021)
            8.8.1.3    Forecast Trend (2022-2027)
        8.8.2    Retail Pharmacy
            8.8.2.1    Market Share
            8.8.2.2    Historical Trend (2017-2021)
            8.8.2.3    Forecast Trend (2022-2027)
        8.8.3    Online Pharmacy
            8.8.3.1    Market Share
            8.8.3.2    Historical Trend (2017-2021)
            8.8.3.3    Forecast Trend (2022-2027)
        8.8.4    Others
    8.9    Global Hunter Syndrome Treatment Market by Region
        8.9.1    Market Share
            8.9.1.1    North America
            8.9.1.2    Europe
            8.9.1.3    Asia Pacific
            8.9.1.4    Latin America
            8.9.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    Denali Therapeutics Inc.
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    ArmaGen, Inc.
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Sangamo Therapeutics Inc.
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    CANbridge Life Sciences Ltd.
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    REGENXBIO Inc. 
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Others
12    Industry Events and Developments

 

List of Key Figures and Tables

1.    Global Hunter Syndrome Treatment Market: Key Industry Highlights, 2017 and 2027
2.    Global Hunter Syndrome Treatment Historical Market: Breakup by Treatment (USD Million), 2017-2021
3.    Global Hunter Syndrome Treatment Market Forecast: Breakup by Treatment (USD Million), 2022-2027
4.    Global Hunter Syndrome Treatment Historical Market: Breakup by Complications (USD Million), 2017-2021
5.    Global Hunter Syndrome Treatment Market Forecast: Breakup by Complications (USD Million), 2022-2027
6.    Global Hunter Syndrome Treatment Historical Market: Breakup by Route of Administration (USD Million), 2017-2021
7.    Global Hunter Syndrome Treatment Market Forecast: Breakup by Route of Administration (USD Million), 2022-2027
8.    Global Hunter Syndrome Treatment Historical Market: Breakup by End Use (USD Million), 2017-2021
9.    Global Hunter Syndrome Treatment Market Forecast: Breakup by End Use (USD Million), 2022-2027
10.    Global Hunter Syndrome Treatment Historical Market: Breakup by Distribution Channel (USD Million), 2017-2021
11.    Global Hunter Syndrome Treatment Market Forecast: Breakup by Distribution Channel (USD Million), 2022-2027
12.    Global Hunter Syndrome Treatment Historical Market: Breakup by Region (USD Million), 2017-2021
13.    Global Hunter Syndrome Treatment Market Forecast: Breakup by Region (USD Million), 2022-2027
14.    North America Hunter Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
15.    North America Hunter Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Europe Hunter Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
17.    Europe Hunter Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
18.    Asia Pacific Hunter Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
19.    Asia Pacific Hunter Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
20.    Latin America Hunter Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
21.    Latin America Hunter Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
22.    Middle East and Africa Hunter Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
23.    Middle East and Africa Hunter Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
24.    Global Hunter Syndrome Treatment Market Structure

Key Questions Answered in the Report

In 2021, the global hunter syndrome treatment market attained a value of nearly USD 925 million.

The market is assessed to grow at a CAGR of 6.30% between 2022 and 2027.

The market is estimated to witness healthy growth in the forecast period of 2022-2027 to reach almost USD 1334.6 million by 2027.

The major market drivers are the increasing awareness about rare disease treatments, and advancements in medical sciences, and the surging investments in R&D activities of hunter syndrome treatment.

The key market trends include the growing availability of hunter syndrome treatments, technological advancements and innovations, and growing healthcare infrastructure development.

The major regions in the market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

The various treatment types in the market are enzyme replacement therapy (ERT) and haematopoietic stem cell transplant (HSCT), among others.

The different complications of the hunter syndrome treatment include respiratory disorders, neurological disorders, cardiovascular, musculoskeletal, gastrointestinal disorders, ophthalmic, audiologic, and dental, among others.

The significant routes of administration of hunter treatment syndrome in the market are intravenous and intracerebroventricular (ICV)/ intrathecal.

The major end uses of hunter syndrome treatment, include hospitals and speciality clinics, among others.

The various distribution channels in the market, include hospital pharmacy, online pharmacy, and retail pharmacy, among others.

The major players in the market are Denali Therapeutics Inc., ArmaGen, Inc., Sangamo Therapeutics Inc., CANbridge Life Sciences Ltd., and REGENXBIO Inc., among others.

Analyst Review

The global hunter syndrome treatment market attained a value of nearly USD 925 million in 2021, driven by technological advancements and the robust growth of the healthcare industry. Aided by the growing emergence of novel therapies, the market is expected to witness further growth in the forecast period of 2022-2027, growing at a CAGR of 6.30%. The market is estimated to reach about USD 1334.6 million by 2027.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the market. The market for hunter syndrome treatment, by treatment type, is divided into enzyme replacement therapy (ERT), and haematopoietic stem cell transplant (HSCT), among others. Based on complication, the market is segmented into respiratory disorders, neurological disorders, cardiovascular, musculoskeletal, gastrointestinal disorders, ophthalmic, audiologic, and dental, among others. Based on routes of administration, the market is segmented into intravenous and intracerebroventricular (ICV)/ intrathecal. On the basis of end use, the market is classified into hospitals and speciality clinics, among others. Based on distribution channel, the market is categorised into hospital pharmacy, online pharmacy, and retail pharmacy, among others. The major regional markets for hunter syndrome treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Denali Therapeutics Inc., ArmaGen, Inc., Sangamo Therapeutics Inc., CANbridge Life Sciences Ltd., and REGENXBIO Inc., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER